Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DoximityDOCS -6.05%86 3-Year FCF Growth Rate is 25.20% as of Jun. 2026, which is 10% below its 10-year median of 28.00. GuruFocus rates DOCS with a GF Score™ of 86/100 and a GF Value™ of $45.35 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 467 Healthcare Providers & Services companies, Doximity ranks better than 63.38% on this metric.
During the past 12 months, Doximity's average Free Cash Flow per Share Growth Rate was 5.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 25.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 28.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 8 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Doximity was 97.60% per year. The lowest was 25.20% per year. And the median was 28.00% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Doximity 3-Year FCF Growth Rate Related Terms
DOCS vs PRVA, WAY, HTFL: 3-Year FCF Growth Rate Comparison
For the Health Information Services subindustry, Doximity's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Doximity's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 25.20% mean?
Doximity (DOCS) has a 3-Year FCF Growth Rate of 25.20% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Doximity and its competitors. This is 10% below median its historical median of 28.00. Over the past decade, Doximity's 3-Year FCF Growth Rate has ranged from 25.20 to 97.60. According to the industry distribution chart, Doximity ranks #171 out of 467 companies in the Healthcare Providers & Services industry, placing it in the top 36.6%.
Is Doximity's 3-Year FCF Growth Rate too high?
Doximity's current 3-Year FCF Growth Rate of 25.20% is 10% below median its 10-year median of 28.00. Over the past 10 years, this metric has ranged from a low of 25.20 to a high of 97.60. The Healthcare Providers & Services industry median 3-Year FCF Growth Rate is 12.40. Doximity's value of 25.20% is 103.2% above this industry median. Based on the distribution chart, Doximity ranks #171 out of 467 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Doximity has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's 3-Year FCF Growth Rate compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #171 out of 467 companies for 3-Year FCF Growth Rate. This puts Doximity in the upper half of its industry. The industry median 3-Year FCF Growth Rate is 12.40. Doximity's value of 25.20% is 103.2% above this benchmark. Historically, Doximity's own 3-Year FCF Growth Rate has ranged from 25.20 to 97.60 over the past decade. While the company's 10-year median is 28.00 vs. the industry median of 12.40, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 12.40, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current 3-Year FCF Growth Rate of 25.20% is 103.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Doximity and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 12.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current 3-Year FCF Growth Rate is 25.20%, which is 10% below median its own 10-year median of 28.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $45.35, compared to a current price of $24.98 — trading 44.9% below its estimated fair value. The current 3-Year FCF Growth Rate is 25.20%, which is 10% below median its 10-year median of 28.00 and 103.2% above the Healthcare Providers & Services industry median of 12.40. Doximity's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Doximity (DOCS), the current 3-Year FCF Growth Rate is 25.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $24.98 is trading 44.9% below its estimated GF Value™ of $45.35.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
3-Year FCF Growth Rate: 25.20% (10% below median its 10-year median of 28.00)
GF Value™: $45.35 vs. price of $24.98 (44.9% below fair value)
Industry Position: 103.2% above the Healthcare Providers & Services median (#171 of 467)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
86GF Score
Get the complete analysis for DOCS
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
